Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001
(2001; 6 pages) [French] [Spanish] View the PDF document
Abstract
In joining the WTO, Members adhere to 18 specific agreements annexed to the Agreement establishing the WTO. They cannot choose to be party to some agreements but not others (with the exception of a few “plurilateral” agreements that are not obligatory). Of greatest relevance to the health sector are: the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS); the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS); the Agreement on Technical Barriers to Trade (TBT); the General Agreement on Tariffs and Trade (GATT); and the General Agreement on Trade in Services (GATS). Of these agreements, TRIPS is expected to have the greatest impact on the pharmaceutical sector. The TBT Agreement should be of particular concern to producing countries, since its implementation may affect export markets...
Table of Contents
View the documentA new era in global trade
View the documentKey requirements of the TRIPS Agreement
View the documentPublic health and TRIPS
View the documentEvaluating impacts of trade agreements
View the documentWHO perspectives on access to drugs
View the documentFurther reading
View the documentContacts at WHO Headquarters:
 

Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001

WHO/EDM/2001.2
Original: English
Distr.: General

No. 3 March 2001
World Health Organization
Geneva

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014